Nature Communications (Dec 2024)

Tumor-derived miR-9-5p-loaded EVs regulate cholesterol homeostasis to promote breast cancer liver metastasis in mice

  • Mei-Xin Li,
  • Sheng Hu,
  • He-Hua Lei,
  • Meng Yuan,
  • Xu Li,
  • Wen-Kui Hou,
  • Xiang-Jie Huang,
  • Bing-Wen Xiao,
  • Teng-Xiang Yu,
  • Xiao-Hui Zhang,
  • Xiao-Ting Wu,
  • Wen-Qiang Jing,
  • Hyeon-Jeong Lee,
  • Juan-Juan Li,
  • Da Fu,
  • Li-Min Zhang,
  • Wei Yan

DOI
https://doi.org/10.1038/s41467-024-54706-z
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 20

Abstract

Read online

Abstract Cancer cells secrete extracellular vesicles (EV) encapsulating bioactive cargoes to facilitate inter-organ communication in vivo and are emerging as critical mediators of tumor progression and metastasis, a condition which is often accompanied by a dysregulated cholesterol metabolism. Whether EVs are involved in the control of cholesterol homeostasis during tumor metastasis is still undefined and warrant further investigation. Here, we find that breast cancer-derived exosomal miR-9-5p induces the expression of HMGCR and CH25H, two enzymes involved in cholesterol synthesis and the conversion of 25-hydroxycholesterol from cholesterol by targeting INSIG1, INSIG2 and ATF3 genes in the liver. Notably, in vivo miR-9-5p antagomir treatment and genetic CH25H ablation prevents tumor metastasis in a mouse model of breast cancer. Thus, our findings reveal the regulatory mechanism of tumor-derived miR-9-5p in liver metastasis by linking oxysterol metabolism and Kupffer cell polarization, shedding light on future applications for cancer diagnosis and treatment.